Over the last 20 years, opioid abuse has become increasingly prevalent in the United States. The graph above shows the number of overdose fatalities involving any opioid between 1999-2018.
In 1996, Purdue Pharma released a new prescription opioid called OxyContin with an aggressive marketing strategy. This included targeting physicians who were the highest prescribers of opioids across the country, including physicians whose patients may not have needed OxyContin. This was all being carried out with the knowledge that the drug is addictive. By 2004, OxyContin was among the most abused drugs in the U.S.
The principal owners of Purdue Pharma were members of the Sackler family, who, as problems arose and lawsuits against the company began to be filed, withdrew over $10 billion from the privately held firm to ensure their own financial well-being. Due to litigation, Purdue Pharma filed for bankruptcy in 2019.
I am not asserting that Purdue Pharma and the Sackler family are responsible for the dramatic increase in opioid abuse in America. But, they certainly played a role by recklessly marketing what would become one of the most abused drugs in the county.
On Thursday, I questioned Craig Landau, President and CEO of Purdue Pharma, and David Sackler, former member of Purdue Pharma's board of directors, at a House Oversight and Reform Committee hearing about why they so aggressively marketed OxyContin and their role in the opioid crisis in America. You can watch my questioning by clicking on the video below